Contrasting effects of phentolamine and nitroprusside on neural and cardiovascular variability

Philippe Van De Borne, Mohsen Rahnama, Silvia Mezzetti, Nicola Montano, Alberto Porta, Jean Paul Degaute, Virend K. Somers

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

The relative contributions of a central neural oscillator and of the delay in α-adrenergic transmission within the baroreflex loop in the predominance of low-frequency (LF) cardiovascular variability during sympathetic activation in humans are unclear. We measured R-R interval (RR), muscle sympathetic nerve activity (MSNA), blood pressure (BP), and their variability in 10 normal subjects during sympathetic activation achieved by BP lowering with sodium nitroprusside (SNP) and α-adrenergic blockade using phentolamine. SNP and phentolamine induced comparable reductions in BP (P > 0.25). Despite tachycardia and sympathetic activation with both SNP and phentolamine, LF variability in RR, MSNA, and BP increased during SNP and decreased during phentolamine (SNP: RR +20 ± 6%, MSNA +3 ± 5%, systolic BP +9 ± 6%, diastolic BP +7 ± 5%; phentolamine: RR -2 ± 7%, MSNA -34 ± 6%, systolic BP -16 ± 8%, diastolic BP -13 ± 4%, P <0.05 except systolic BP, where P = 0.09). Thus LF variability is reduced when sympathetic activation is induced by α-adrenergic blockade. This suggests that α-adrenergic transmission within the baroreflex loop may contribute importantly to the predominance of LF cardiovascular variability associated with sympathetic excitation in humans.

Original languageEnglish
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume281
Issue number2 50-2
Publication statusPublished - 2001

Fingerprint

Phentolamine
Nitroprusside
Blood Pressure
Adrenergic Agents
Muscles
Baroreflex
Tachycardia

Keywords

  • Sympathetic nervous system

ASJC Scopus subject areas

  • Physiology
  • Physiology (medical)

Cite this

Contrasting effects of phentolamine and nitroprusside on neural and cardiovascular variability. / Van De Borne, Philippe; Rahnama, Mohsen; Mezzetti, Silvia; Montano, Nicola; Porta, Alberto; Degaute, Jean Paul; Somers, Virend K.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 281, No. 2 50-2, 2001.

Research output: Contribution to journalArticle

Van De Borne, Philippe ; Rahnama, Mohsen ; Mezzetti, Silvia ; Montano, Nicola ; Porta, Alberto ; Degaute, Jean Paul ; Somers, Virend K. / Contrasting effects of phentolamine and nitroprusside on neural and cardiovascular variability. In: American Journal of Physiology - Heart and Circulatory Physiology. 2001 ; Vol. 281, No. 2 50-2.
@article{55ffab6edf4f46678fce603207e95187,
title = "Contrasting effects of phentolamine and nitroprusside on neural and cardiovascular variability",
abstract = "The relative contributions of a central neural oscillator and of the delay in α-adrenergic transmission within the baroreflex loop in the predominance of low-frequency (LF) cardiovascular variability during sympathetic activation in humans are unclear. We measured R-R interval (RR), muscle sympathetic nerve activity (MSNA), blood pressure (BP), and their variability in 10 normal subjects during sympathetic activation achieved by BP lowering with sodium nitroprusside (SNP) and α-adrenergic blockade using phentolamine. SNP and phentolamine induced comparable reductions in BP (P > 0.25). Despite tachycardia and sympathetic activation with both SNP and phentolamine, LF variability in RR, MSNA, and BP increased during SNP and decreased during phentolamine (SNP: RR +20 ± 6{\%}, MSNA +3 ± 5{\%}, systolic BP +9 ± 6{\%}, diastolic BP +7 ± 5{\%}; phentolamine: RR -2 ± 7{\%}, MSNA -34 ± 6{\%}, systolic BP -16 ± 8{\%}, diastolic BP -13 ± 4{\%}, P <0.05 except systolic BP, where P = 0.09). Thus LF variability is reduced when sympathetic activation is induced by α-adrenergic blockade. This suggests that α-adrenergic transmission within the baroreflex loop may contribute importantly to the predominance of LF cardiovascular variability associated with sympathetic excitation in humans.",
keywords = "Sympathetic nervous system",
author = "{Van De Borne}, Philippe and Mohsen Rahnama and Silvia Mezzetti and Nicola Montano and Alberto Porta and Degaute, {Jean Paul} and Somers, {Virend K.}",
year = "2001",
language = "English",
volume = "281",
journal = "American Journal of Physiology",
issn = "0363-6119",
publisher = "American Physiological Society",
number = "2 50-2",

}

TY - JOUR

T1 - Contrasting effects of phentolamine and nitroprusside on neural and cardiovascular variability

AU - Van De Borne, Philippe

AU - Rahnama, Mohsen

AU - Mezzetti, Silvia

AU - Montano, Nicola

AU - Porta, Alberto

AU - Degaute, Jean Paul

AU - Somers, Virend K.

PY - 2001

Y1 - 2001

N2 - The relative contributions of a central neural oscillator and of the delay in α-adrenergic transmission within the baroreflex loop in the predominance of low-frequency (LF) cardiovascular variability during sympathetic activation in humans are unclear. We measured R-R interval (RR), muscle sympathetic nerve activity (MSNA), blood pressure (BP), and their variability in 10 normal subjects during sympathetic activation achieved by BP lowering with sodium nitroprusside (SNP) and α-adrenergic blockade using phentolamine. SNP and phentolamine induced comparable reductions in BP (P > 0.25). Despite tachycardia and sympathetic activation with both SNP and phentolamine, LF variability in RR, MSNA, and BP increased during SNP and decreased during phentolamine (SNP: RR +20 ± 6%, MSNA +3 ± 5%, systolic BP +9 ± 6%, diastolic BP +7 ± 5%; phentolamine: RR -2 ± 7%, MSNA -34 ± 6%, systolic BP -16 ± 8%, diastolic BP -13 ± 4%, P <0.05 except systolic BP, where P = 0.09). Thus LF variability is reduced when sympathetic activation is induced by α-adrenergic blockade. This suggests that α-adrenergic transmission within the baroreflex loop may contribute importantly to the predominance of LF cardiovascular variability associated with sympathetic excitation in humans.

AB - The relative contributions of a central neural oscillator and of the delay in α-adrenergic transmission within the baroreflex loop in the predominance of low-frequency (LF) cardiovascular variability during sympathetic activation in humans are unclear. We measured R-R interval (RR), muscle sympathetic nerve activity (MSNA), blood pressure (BP), and their variability in 10 normal subjects during sympathetic activation achieved by BP lowering with sodium nitroprusside (SNP) and α-adrenergic blockade using phentolamine. SNP and phentolamine induced comparable reductions in BP (P > 0.25). Despite tachycardia and sympathetic activation with both SNP and phentolamine, LF variability in RR, MSNA, and BP increased during SNP and decreased during phentolamine (SNP: RR +20 ± 6%, MSNA +3 ± 5%, systolic BP +9 ± 6%, diastolic BP +7 ± 5%; phentolamine: RR -2 ± 7%, MSNA -34 ± 6%, systolic BP -16 ± 8%, diastolic BP -13 ± 4%, P <0.05 except systolic BP, where P = 0.09). Thus LF variability is reduced when sympathetic activation is induced by α-adrenergic blockade. This suggests that α-adrenergic transmission within the baroreflex loop may contribute importantly to the predominance of LF cardiovascular variability associated with sympathetic excitation in humans.

KW - Sympathetic nervous system

UR - http://www.scopus.com/inward/record.url?scp=0034887854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034887854&partnerID=8YFLogxK

M3 - Article

C2 - 11454557

AN - SCOPUS:0034887854

VL - 281

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6119

IS - 2 50-2

ER -